Efficacy and safety of bortezomib in rituximab-resistant anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis as well as the clinical characteristics: An observational study
Tingting Wang, Baojie Wang, Ziling Zeng, Honghao Li, Fusheng Zhang, Xiyun Ruan, Chunjuan Wang, Shougang Guo
Topics & Concepts
BortezomibMedicineRituximabInternal medicineAntibodyImmune systemEncephalitisImmunologyMultiple myelomaVirusAutoimmune Neurological Disorders and TreatmentsGenetics and Neurodevelopmental DisordersChronic Lymphocytic Leukemia Research